✦ LIBER ✦

Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms

✍ Scribed by Ordás, I; Mould, D R; Feagan, B G; Sandborn, W J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of a third anti-TNF mo

✍ P. S. A. de Silva; D. D. Nguyen; J. Sauk; J. Korzenik; V. Yajnik; A. N. Ananthak 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Systematic review: antibodies and anti-T

✍ M. Chaparro; I. Guerra; P. Muñoz-Linares; J. P. Gisbert 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

P305 - The molecular mechanism of action

✍ R. Atreya; M. Zimmer; B. Bartsch; M.F. Neurath 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 112 KB

Murine Monoclonal Anti-TNF Antibody Admi

✍ Raia Gratz; Stuart Becker; Nadia Sokolowski; Marcus Schumann; David Bass; Stephe 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 293 KB

P381 Predictors and frequency of anti-TN

✍ Viazis, N.; Koukouratos, T.; Anastasiou, J.; Saprikis, E.; Kechagias, G.; Katopo 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 48 KB

P539 Dose intensification with anti-TNF

✍ Kothegal Marimahadevappa, G.; Limdi, J.K. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 49 KB